Europe Point-Of-Care Molecular Diagnostics Market (2025 - 2030) Size, Share & Trends Analysis Report By Application (Infectious Disease, Oncology), By Test Location, By Technology (PCR Based, Genetic Sequencing Based), By End Use, By Country, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                     1.1. Market Segmentation & Scope
                     1.2. Segment Definitions
                          1.2.1. Application
                          1.2.2. Test Location
                          1.2.3. Technology
                          1.2.4. End Use
                          1.2.5. Country
                     1.3. Estimates and Forecast Timeline
                     1.4. Research Methodology
                     1.5. Information Procurement
                          1.5.1. Purchased Database
                          1.5.2. GVR’s Internal Database
                          1.5.3. Secondary Sources
                          1.5.4. Primary Research
                     1.6. Information Analysis
                          1.6.1. Data Analysis Models
                     1.7. Market Formulation & Data Visualization
                     1.8. Model Details
                          1.8.1. Commodity Flow Analysis
                     1.9. List of Secondary Sources
                     1.10. Objectives
Chapter 2. Executive Summary
                     2.1. Market Snapshot
                     2.2. Segment Snapshot
                     2.3. Competitive Landscape Snapshot
Chapter 3. Europe Point-Of-Care Molecular Diagnostics Market Variables, Trends, & Scope
                     3.1. Market Lineage Outlook
                     3.2. Market Dynamics
                          3.2.1. Market Driver Analysis
                          3.2.2. Market Restraint Analysis
                     3.3. Business Environment Analysis
                          3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                               3.3.1.1. Supplier Power
                               3.3.1.2. Buyer Power
                               3.3.1.3. Substitution Threat
                               3.3.1.4. Threat of New Entrants
                               3.3.1.5. Competitive Rivalry
                          3.3.2. PESTLE Analysis
Chapter 4. Europe Point-Of-Care Molecular Diagnostics Market: Application Estimates & Trend Analysis
                     4.1. Application Market Share, 2024 & 2030
                     4.2. Application Segment Dashboard
                     4.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
                     4.4. Infectious Diseases
                          4.4.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
                          4.4.2. HIV POC
                               4.4.2.1. HIV POC Market, 2018 - 2030 (USD Million)
                          4.4.3. Clostridium Difficile POC
                               4.4.3.1. Clostridium Difficile POC Market, 2018 - 2030 (USD Million)
                          4.4.4. HBV POC
                               4.4.4.1. HBV POC Market, 2018 - 2030 (USD Million)
                          4.4.5. Pneumonia Or Streptococcus Associated Infections
                               4.4.5.1. Pneumonia Or Streptococcus Associated Infections Market, 2018 - 2030 (USD Million)
                          4.4.6. Respiratory Syncytial Virus (RSV) POC
                               4.4.6.1. Respiratory Syncytial Virus (RSV) POC Market, 2018 - 2030 (USD Million)
                          4.4.7. HPV POC
                               4.4.7.1. HPV POC Market, 2018 - 2030 (USD Million)
                          4.4.8. Influenza/Flu POC
                               4.4.8.1. Influenza/Flu POC Market, 2018 - 2030 (USD Million)
                          4.4.9. HCV POC
                               4.4.9.1. HCV POC Market, 2018 - 2030 (USD Million)
                          4.4.10. MRSA POC
                               4.4.10.1. MRSA POC Market, 2018 - 2030 (USD Million)
                          4.4.11. TB And Drug-Resistant TB POC
                               4.4.11.1. TB And Drug-Resistant TB POC Market, 2018 - 2030 (USD Million)
                          4.4.12. HSV POC
                               4.4.12.1. HSV POC Market, 2018 - 2030 (USD Million)
                          4.4.13. Other Infectious Diseases
                               4.4.13.1. Other Infectious Diseases Market, 2018 - 2030 (USD Million)
                     4.5. Oncology
                          4.5.1. Oncology Market, 2018 - 2030 (USD Million)
                     4.6. Hematology
                          4.6.1. Oncology Market, 2018 - 2030 (USD Million)
                          4.6.2. Complete Blood Count (CBC)
                               4.6.2.1. Complete Blood Count (CBC) Market, 2018 - 2030 (USD Million)
                          4.6.3. Prothrombin Time (PT)
                               4.6.3.1. Complete Blood Count (CBC) Market, 2018 - 2030 (USD Million)
                          4.6.4. Partial Thromboplastin Time (PTT)
                               4.6.4.1. Partial Thromboplastin Time (PTT) Market, 2018 - 2030 (USD Million)
                          4.6.5. Others
                               4.6.5.1. Others Market, 2018 - 2030 (USD Million)
                          4.6.6. Prenatal Testing
                               4.6.6.1. Prenatal Testing Market, 2018 - 2030 (USD Million)
                          4.6.7. Endocrinology
                               4.6.7.1. Endocrinology Market, 2018 - 2030 (USD Million)
                          4.6.8. Other Applications
                               4.6.8.1. Other Applications Market, 2018 - 2030 (USD Million)
Chapter 5. Europe Point-Of-Care Molecular Diagnostics Market: Test Location Estimates & Trend Analysis
                     5.1. Test Location Market Share, 2024 & 2030
                     5.2. Test Location Segment Dashboard
                     5.3. Market Size & Forecasts and Trend Analysis, by Test Location, 2018 to 2030 (USD Million)
                     5.4. OTC
                          5.4.1. OTC Market, 2018 - 2030 (USD Million)
                     5.5. POC
                          5.5.1. POC Market, 2018 - 2030 (USD Million)
Chapter 6. Europe Point-Of-Care Molecular Diagnostics Market: Technology Estimates & Trend Analysis
                     6.1. Technology Market Share, 2024 & 2030
                     6.2. Technology Segment Dashboard
                     6.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
                     6.4. PCR-based
                          6.4.1. PCR-based Market, 2018 - 2030 (USD Million)
                     6.5. Genetic Sequencing-based
                          6.5.1. Genetic Sequencing-based Market, 2018 - 2030 (USD Million)
                     6.6. Hybridization-based
                          6.6.1. Hybridization-based Market, 2018 - 2030 (USD Million)
                     6.7. Microarray-based
                          6.7.1. Microarray-based Market, 2018 - 2030 (USD Million)
Chapter 7. Europe point-of-care molecular diagnostics Market: End Use Estimates & Trend Analysis
                     7.1. End Use Channel Market Share, 2024 & 2030
                     7.2. End Use Channel Segment Dashboard
                     7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
                     7.4. Decentralized Labs
                          7.4.1. Decentralized Labs Market, 2018 - 2030 (USD Million)
                     7.5. Hospitals
                          7.5.1. Hospitals Market, 2018 - 2030 (USD Million)
                     7.6. Home-care
                          7.6.1. Home-care Market, 2018 - 2030 (USD Million)
                     7.7. Assisted Living Healthcare Facilities
                          7.7.1. Assisted Living Healthcare Facilities Market, 2018 - 2030 (USD Million)
                     7.8. Other Uses
                          7.8.1. Other Uses Market, 2018 - 2030 (USD Million)
Chapter 8. Medical Carts Market: Country Estimates & Trend Analysis
                     8.1. Country Market Share Analysis, 2024 & 2030
                     8.2. Country Market Dashboard
                     8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
                          8.3.1. UK
                               8.3.1.1. Key Country Dynamics
                               8.3.1.2. Regulatory Framework
                               8.3.1.3. Competitive Insights
                          8.3.2. Germany
                               8.3.2.1. Key Country Dynamics
                               8.3.2.2. Regulatory Framework
                               8.3.2.3. Competitive Insights
                          8.3.3. France
                               8.3.3.1. Key Country Dynamics
                               8.3.3.2. Regulatory Framework
                               8.3.3.3. Competitive Insights
                          8.3.4. Italy
                               8.3.4.1. Key Country Dynamics
                               8.3.4.2. Regulatory Framework
                               8.3.4.3. Competitive Insights
                          8.3.5. Spain
                               8.3.5.1. Key Country Dynamics
                               8.3.5.2. Regulatory Framework
                               8.3.5.3. Competitive Insights
                          8.3.6. Denmark
                               8.3.6.1. Key Country Dynamics
                               8.3.6.2. Regulatory Framework
                               8.3.6.3. Competitive Insights
                          8.3.7. Sweden
                               8.3.7.1. Key Country Dynamics
                               8.3.7.2. Regulatory Framework
                               8.3.7.3. Competitive Insights
                          8.3.8. Norway
                               8.3.8.1. Key Country Dynamics
                               8.3.8.2. Regulatory Framework
                               8.3.8.3. Competitive Insights
                          8.3.9. Russia
                               8.3.9.1. Key Country Dynamics
                               8.3.9.2. Regulatory Framework
                               8.3.9.3. Competitive Insights
                          8.3.10. Netherlands
                               8.3.10.1. Key Country Dynamics
                               8.3.10.2. Regulatory Framework
                               8.3.10.3. Competitive Insights
Chapter 9. Competitive Landscape
                     9.1. Participant Overview
                     9.2. Company Market Position Analysis
                     9.3. Company Categorization
                     9.4. Strategy Mapping
                     9.5. Company Profiles/Listing
                          9.5.1. Abbott
                               9.5.1.1. Overview
                               9.5.1.2. Financial Performance
                               9.5.1.3. Product Benchmarking
                               9.5.1.4. Strategic Initiatives
                          9.5.2. QIAGEN
                               9.5.2.1. Overview
                               9.5.2.2. Financial Performance
                               9.5.2.3. Product Benchmarking
                               9.5.2.4. Strategic Initiatives
                          9.5.3. Bayer AG
                               9.5.3.1. Overview
                               9.5.3.2. Financial Performance
                               9.5.3.3. Product Benchmarking
                               9.5.3.4. Strategic Initiatives
                          9.5.4. Nova Biomedical
                               9.5.4.1. Overview
                               9.5.4.2. Financial Performance
                               9.5.4.3. Product Benchmarking
                               9.5.4.4. Strategic Initiatives
                          9.5.5. Danaher
                               9.5.5.1. Overview
                               9.5.5.2. Financial Performance
                               9.5.5.3. Product Benchmarking
                               9.5.5.4. Strategic Initiatives
                          9.5.6. Nipro Diagnostics (Nipro Europe Group Companies)
                               9.5.6.1. Overview
                               9.5.6.2. Financial Performance
                               9.5.6.3. Product Benchmarking
                               9.5.6.4. Strategic Initiatives
                          9.5.7. Bio-Rad Laboratories, Inc.
                               9.5.7.1. Overview
                               9.5.7.2. Financial Performance
                               9.5.7.3. Product Benchmarking
                               9.5.7.4. Strategic Initiatives
                          9.5.8. Agilent Technologies, Inc.
                               9.5.8.1. Overview
                               9.5.8.2. Financial Performance
                               9.5.8.3. Product Benchmarking
                               9.5.8.4. Strategic Initiatives
                          9.5.9. BIOMÉRIEUX
                               9.5.9.1. Overview
                               9.5.9.2. Financial Performance
                               9.5.9.3. Product Benchmarking
                               9.5.9.4. Strategic Initiatives
                          9.5.10. OraSure Technologies Inc.
                               9.5.10.1. Overview
                               9.5.10.2. Financial Performance
                               9.5.10.3. Product Benchmarking
                               9.5.10.4. Strategic Initiatives
                          9.5.11. Abaxis
                               9.5.11.1. Overview
                               9.5.11.2. Financial Performance
                               9.5.11.3. Product Benchmarking
                               9.5.11.4. Strategic Initiatives 

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Europe point-of-care molecular diagnostics market, by country, 2018 - 2030 (USD Million)
Table 4. Europe point-of-care molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 5. Europe point-of-care molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
Table 6. Europe point-of-care molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 7. Europe point-of-care molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 8. UK point-of-care molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 9. UK point-of-care molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
Table 10. UK point-of-care molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 11. UK point-of-care molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 12. Germany point-of-care molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 13. Germany point-of-care molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
Table 14. Germany point-of-care molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 15. Germany point-of-care molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 16. France point-of-care molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 17. France point-of-care molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
Table 18. France point-of-care molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 19. France point-of-care molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 20. Italy point-of-care molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 21. Italy point-of-care molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
Table 22. Italy point-of-care molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 23. Italy point-of-care molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 24. Spain point-of-care molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 25. Spain point-of-care molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
Table 26. Spain point-of-care molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 27. Spain point-of-care molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 28. Denmark point-of-care molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 29. Denmark point-of-care molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
Table 30. Denmark point-of-care molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 31. Denmark point-of-care molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 32. Sweden point-of-care molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 33. Sweden point-of-care molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
Table 34. Sweden point-of-care molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 35. Sweden point-of-care molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 36. Norway point-of-care molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 37. Norway point-of-care molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
Table 38. Norway point-of-care molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 39. Norway point-of-care molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 40. Russia point-of-care molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 41. Russia point-of-care molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
Table 42. Russia point-of-care molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 43. Russia point-of-care molecular diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 44. Netherlands point-of-care molecular diagnostics market, by application, 2018 - 2030 (USD Million)
Table 45. Netherlands point-of-care molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
Table 46. Netherlands point-of-care molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 47. Netherlands point-of-care molecular diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Europe point-of-care molecular diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Application and test location outlook (USD Million)
Fig. 10 Technology and end use outlook (USD Million)
Fig. 11 Competitive landscape
Fig. 12 Europe point-of-care molecular diagnostics market dynamics
Fig. 13 Europe point-of-care molecular diagnostics market: Porter’s five forces analysis
Fig. 14 Europe point-of-care molecular diagnostics market: PESTLE analysis
Fig. 15 Europe point-of-care molecular diagnostics market: Application segment dashboard
Fig. 16 Europe point-of-care molecular diagnostics market: Application market share analysis, 2024 & 2030
Fig. 17 Infectious diseases market, 2018 - 2030 (USD Million)
Fig. 18 HIV POC market, 2018 - 2030 (USD Million)
Fig. 19 Clostridium difficile POC market, 2018 - 2030 (USD Million)
Fig. 20 HBV POC market, 2018 - 2030 (USD Million)
Fig. 21 Pneumonia or streptococcus associated infections market, 2018 - 2030 (USD Million)
Fig. 22 Respiratory Syncytial Virus (RSV) POC market, 2018 - 2030 (USD Million)
Fig. 23 HPV POC market, 2018 - 2030 (USD Million)
Fig. 24 Influenza/Flu POC market, 2018 - 2030 (USD Million)
Fig. 25 HCV POC market, 2018 - 2030 (USD Million)
Fig. 26 MRSA POC market, 2018 - 2030 (USD Million)
Fig. 27 TB and drug-resistant TB POC market, 2018 - 2030 (USD Million)
Fig. 28 HSV POC market, 2018 - 2030 (USD Million)
Fig. 29 Other infectious diseases market, 2018 - 2030 (USD Million)
Fig. 30 Oncology market, 2018 - 2030 (USD Million)
Fig. 31 Hematology market, 2018 - 2030 (USD Million)
Fig. 32 Prenatal testing market, 2018 - 2030 (USD Million)
Fig. 33 Endocrinology market, 2018 - 2030 (USD Million)
Fig. 34 Other applications market, 2018 - 2030 (USD Million)
Fig. 35 Europe point-of-care molecular diagnostics market: Test location segment dashboard
Fig. 36 Europe point-of-care molecular diagnostics market: Test location market share analysis, 2024 & 2030
Fig. 37 OTC market, 2018 - 2030 (USD Million)
Fig. 38 POC market, 2018 - 2030 (USD Million)
Fig. 39 Europe point-of-care molecular diagnostics market : Technology segment dashboard
Fig. 40 Europe point-of-care molecular diagnostics market: Technology market share analysis, 2024 & 2030
Fig. 41 PCR-based market, 2018 - 2030 (USD Million)
Fig. 42 Genetic Sequencing-based market, 2018 - 2030 (USD Million)
Fig. 43 Hybridization-based market, 2018 - 2030 (USD Million)
Fig. 44 Microarray-based market, 2018 - 2030 (USD Million)
Fig. 45 Europe point-of-care molecular diagnostics market : End use segment dashboard
Fig. 46 Europe point-of-care molecular diagnostics market: End use market share analysis, 2024 & 2030
Fig. 47 Decentralized labs market, 2018 - 2030 (USD Million)
Fig. 48 Hospitals market, 2018 - 2030 (USD Million)
Fig. 49 Home-care market, 2018 - 2030 (USD Million)
Fig. 50 Assisted living healthcare facilities market, 2018 - 2030 (USD Million)
Fig. 51 Other uses market, 2018 - 2030 (USD Million)
Fig. 52 Europe point-of-care molecular diagnostics market : Country segment dashboard
Fig. 53 Europe point-of-care molecular diagnostics market: Country channel market share analysis, 2024 & 2030
Fig. 54 Hospital pharmacies market, 2018 - 2030 (USD Million)
Fig. 55 Retail pharmacies market, 2018 - 2030 (USD Million)
Fig. 56 Others market, 2018 - 2030 (USD Million)
Fig. 57 Europe point-of-care molecular diagnostics market : Country segment dashboard
Fig. 58 Europe point-of-care molecular diagnostics market: Country market share analysis, 2024 & 2030
Fig. 59 UK
Fig. 60 UK market, 2018 - 2030 (USD Million)
Fig. 61 Germany
Fig. 62 Germany market, 2018 - 2030 (USD Million)
Fig. 63 France
Fig. 64 France market, 2018 - 2030 (USD Million)
Fig. 65 Italy
Fig. 66 Italy market, 2018 - 2030 (USD Million)
Fig. 67 Spain
Fig. 68 Spain market, 2018 - 2030 (USD Million)
Fig. 69 Denmark
Fig. 70 Denmark market, 2018 - 2030 (USD Million)
Fig. 71 Sweden
Fig. 72 Sweden market, 2018 - 2030 (USD Million)
Fig. 73 Norway
Fig. 74 Norway market, 2018 - 2030 (USD Million)
Fig. 75 Russia
Fig. 76 Russia market, 2018 - 2030 (USD Million)
Fig. 77 Netherlands
Fig. 78 Netherlands market, 2018 - 2030 (USD Million)
Fig. 79 Company categorization
Fig. 80 Company market position analysis
Fig. 81 Strategic framework